Literature DB >> 16767698

Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways.

Y Noutomi1, A Oga, K Uchida, M Okafuji, M Ita, S Kawauchi, T Furuya, Y Ueyama, K Sasaki.   

Abstract

To clarify the genetic pathway(s) involved in the development and progression of oral squamous cell carcinoma (OSCC), as well as the relationship between genetic aberrations and biological characteristics of OSCC tumours, comparative genomic hybridization was used to analyse genetic alterations in both primary OSCCs and adjacent dysplastic lesions of the same biopsy specimens from 35 patients. Gain of 8q22-23 was the most frequent alteration in both OSCC and mild dysplasia, and was considered the earliest event in the process of oral tumourigenesis. The average number of DNA sequence copy number aberrations (DSCNAs) increased with progression from mild dysplasia to invasive carcinoma (r = 0.737, n = 70, p < 0.001). OSCC samples were classified as having a large or small number of DSCNAs (OSCC-L, 21.4 +/- 4.7 DSCNAs or OSCC-S, 10.0 +/- 1.7 DSCNAs, respectively; p < 0.0001). Gains of 3q26-qter, 8q, 11q13, 14q, and 20q and losses of 4q, 5q12-22, 6q, 8p, 13q, and 18q22-qter were common to OSCC-L and OSCC-S. Gains of 5p15, 7p, 17q11-22, and 18p and losses of 3p14-21, 4p, and 9p were detected exclusively in OSCC-L. The average number of DSCNAs depended on whether the samples showed OSCC- L or dysplasia plus OSCC-L, or showed OSCC-S or dysplasia plus OSCC-S (p = 0.001). Gain of 5p15 and losses of 4p and 9p were detected even in dysplastic lesions adjacent to OSCC-L samples. Loss of 4p was associated with node metastasis by multivariate analysis (p = 0.013). OSCC-L tumours were more often T3-T4 stage tumours than T1-T2 stage tumours (p = 0.03). These findings suggest that two different types of OSCC, OSCC-L associated with high-stage cancer and OSCC-S associated with low-stage cancer, arise from different types of dysplasia via different genetic pathways. Copyright (c) 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767698     DOI: 10.1002/path.2015

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Clinicopathological and prognostic implications of genetic alterations in oral cancers.

Authors:  Swapnali M Pathare; Moritz Gerstung; Niko Beerenwinkel; Alejandro A Schäffer; Sadhana Kannan; Prathamesh Pai; K Alok Pathak; Anita M Borges; Manoj B Mahimkar
Journal:  Oncol Lett       Date:  2011-05       Impact factor: 2.967

2.  Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.

Authors:  Ivy F L Tsui; Catherine F Poh; Cathie Garnis; Miriam P Rosin; Lewei Zhang; Wan L Lam
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

3.  Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression.

Authors:  Swapnali Pathare; Alejandro A Schäffer; Niko Beerenwinkel; Manoj Mahimkar
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

4.  Multiple aberrations of chromosome 3p detected in oral premalignant lesions.

Authors:  Ivy F L Tsui; Miriam P Rosin; Lewei Zhang; Raymond T Ng; Wan L Lam
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

5.  [HPV-associated head and neck cancer : mutational signature and genomic aberrations].

Authors:  S Wagner; N Würdemann; C Hübbers; M Reuschenbach; E-S Prigge; G Wichmann; J Hess; A Dietz; M Dürst; I Tinhofer; M von Knebel-Döberitz; C Wittekindt; J P Klussmann
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

6.  Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.

Authors:  W Giaretti; M Maffei; M Pentenero; P Scaruffi; A Donadini; E Di Nallo; D Malacarne; R Marino; U Familiari; S Coco; G P Tonini; P Castagnola; S Gandolfo
Journal:  Cell Oncol (Dordr)       Date:  2011-12-06       Impact factor: 6.730

7.  Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues.

Authors:  Katumi Tsuji; Shigeto Kawauchi; Soichiro Saito; Tomoko Furuya; Kenzo Ikemoto; Motonao Nakao; Shigeru Yamamoto; Masaaki Oka; Takashi Hirano; Kohsuke Sasaki
Journal:  BMC Cancer       Date:  2010-01-14       Impact factor: 4.430

8.  Genomic profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization.

Authors:  Shunichi Yoshioka; Yoshiyuki Tsukamoto; Naoki Hijiya; Chisato Nakada; Tomohisa Uchida; Keiko Matsuura; Ichiro Takeuchi; Masao Seto; Kenji Kawano; Masatsugu Moriyama
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

9.  Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma.

Authors:  Brenen W Papenberg; James Ingles; Si Gao; Jun Feng; Jessica L Allen; Steven M Markwell; Erik T Interval; Phillip A Montague; Sijin Wen; Scott A Weed
Journal:  Cancer Genet       Date:  2021-05-28

10.  Identification of novel genomic aberrations in AML-M5 in a level of array CGH.

Authors:  Rui Zhang; Ji-Yun Lee; Xianfu Wang; Weihong Xu; Xiaoxia Hu; Xianglan Lu; Yimeng Niu; Rurong Tang; Shibo Li; Yan Li
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.